SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SOUN is trending as investors digest recent developments, including strong revenue growth and key partnerships, against a backdrop of broader market volatility and government shutdown concerns. The community is focused on the disconnect between the company's fundamentals and the stock's price action, while some anticipate a potential short squeeze.

WorldFinancial

WorldFinancial ($WLFI) is trending amid community discussions about its potential, particularly regarding upcoming features like a debit card, app, and borrowing/lending options. Bullish sentiment revolves around its association with the Trump family and potential integration with USD1. However, some investors express concern over recent price action and question the coin's fundamentals and long-term viability, while others cite insider activity.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses its potential breakout from a multi-year channel, with some analysts predicting substantial price increases. Speculation around upcoming ETF approvals and the end of the government shutdown are adding to the bullish sentiment. Traders are closely watching key levels, anticipating a significant move if resistance breaks.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors assess the impact of potential government policy changes related to healthcare subsidies and the ACA, with community debates focusing on the company's exposure and long-term prospects. Discussions also include upcoming catalysts such as an investor conference and 13F filings, influencing sentiment around a possible re-rating of the stock. Some traders express concern over potential market impacts from Trump's comments, while others see a buying opportunity amid the uncertainty.

Ethena

Ethena (ENA) is trending as community members discuss its listing on Robinhood and potential correlation with Bitcoin and Ethereum movements.  Some are speculating on future price action, while others point to news around token unlocks and PIPE financing.  The broader conversation highlights Ethena's role in the stablecoin sector.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health ($OSCR) is trending amid discussions surrounding potential ACA subsidy extensions and its impact on the healthcare sector, particularly after competitor earnings reports. Community chatter includes debate around upcoming earnings and the company's long-term potential, with some highlighting its cash reserves and others expressing concern over market conditions. The stock's volatility and sensitivity to broader healthcare policy news are also key talking points.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BBAI is trending as investors discuss the potential impact of an upcoming earnings report and the government shutdown, particularly on government contracts. The community is weighing potential outcomes and speculating on whether positive news or strong guidance could trigger a rally. Some are also noting the company's potential in airport security and AI for government applications, seeing long-term potential despite current volatility.

Prol AI was founded with a clear mission: to make financial market analysis accessible, efficient, and intuitive for everyone. Built by a team of highly skilled software developers and AI specialists, including a PhD-level academic with deep expertise in artificial intelligence, Prol AI combines cutting-edge technology with practical solutions tailored for traders and investors.  Our platform empowers users by simplifying the complexities of financial data, offering tools to interpret charts, analyze trends, and generate actionable insights. Whether you're a seasoned trader or a newcomer to financial markets, Prol AI bridges the gap between raw data and informed decision-making, making advanced financial analysis available to all.

Prol AI

Prol AI ($PROL) is gaining traction, particularly within the Solana ecosystem, with community members highlighting its availability on Phantom and potential for significant movement. Traders are closely watching its chart patterns and anticipating a breakout, emphasizing the use of AI in trading strategies. The overall sentiment suggests confidence in its consolidation and potential for upward momentum.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark ($CLSK) is trending amid discussions about its shift towards AI and high-performance computing, particularly after securing land and power agreements for a new data center in Texas. The community is speculating about potential partnerships with major players like Nvidia, fueled by a recent visit of Cleanspark executives to Nvidia's headquarters. Despite positive developments and bullish analyst ratings, some traders express concerns about the stock's correlation with Bitcoin and its underperformance relative to peers.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

SLAP is gaining attention, with community members expressing strong support and using the term "WAGMI" (We Are All Going To Make It). Conversations highlight the community's enthusiasm and determination, as well as some references to pro athletes, sports and offline promotional activities. The coin is also trending overall on Stocktwits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ADMA Biologics (NASDAQ:ADMA) Posts Quarterly Earnings Results, Meets Estimates

ADMA Biologics (NASDAQ:ADMA - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported $0.16 earnings per share (EPS) for the quarter, meeting the...

ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales

ADMA Biologics posts strong Q3 revenues and record Asceniv demand, but shares slip as higher taxes temper net income growth.

Adma Biologics (ADMA) Q3 Earnings Match Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of 0.00% and +3.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

ADMA Biologics Inc (ADMA) Is a Trending Stock: Facts to Know Before Betting on It

Adma Biologics (ADMA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider

In the closing of the recent trading day, Adma Biologics (ADMA) stood at $15.6, denoting a +2.77% move from the preceding trading day.

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market

Adma Biologics (ADMA) closed at $14.56 in the latest trading session, marking a -3.51% move from the prior day.

Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?

The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Adma Biologics (ADMA) Stock Moves -1.36%: What You Should Know

In the latest trading session, Adma Biologics (ADMA) closed at $14.54, marking a -1.36% move from the previous day.

Why Adma Biologics (ADMA) Outpaced the Stock Market Today

Adma Biologics (ADMA) concluded the recent trading session at $15.05, signifying a +2.66% move from its prior day's close.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

ADMA
Adma Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ADMA News

ADMAAdma Biologics Inc